According to recent reports from Novo Nordisk, insulin should be used by diabetics at an earlier stage as a way to avoid complications and manage the disease more effectively.
A recent study, co-funded by Novo, found that those patients who used injectable insulin rather than oral medication at an early stage were more likely to achieve normal blood glucose levels .
Earlier use will also benefit Novo Nordisk through more widespread sales of the drug. Using insulin more commonly amongst type 2 diabetes sufferers would open a huge market to the insulin manufacturer.
Insulin revenue already accounts for a significant share of the diabetes treatment market, and is climbing faster than oral diabetic medication.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…